Cosmos Health Inc.

COSM.US
Healthcare · Medical Distribution
0.19
-0.01 (-6.03%)
USD · NASDAQ

Company Information

Company Name
Cosmos Health Inc.
Sector
Healthcare
Industry
Medical Distribution
Exchange
NASDAQ
ISIN: US2214133058
CIK: 0001474167
CUSIP: 221413206
Currency: USD
Full Time Employees: 163
Phone: 312 536 3102
Fiscal Year End: December
IPO Date: Oct 11, 2012
Description:

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

Address:

5 Agiou Georgiou Str, Pilea, Thessaloniki, Greece, 55438

People

Directors & Officers

Name Title Year Born
Mr. Grigorios Siokas Chairman & CEO 1965
Mr. Georgios Terzis Chief Financial Officer 1983
Mr. Nikolaos Bardakis Chief Operating Officer 1969
Mr. Demetrios G. Demetriades Secretary & Independent Director 1965
Prof. Dimitrios Trafalis Head of Oncology NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 12, 2026 Grigorios Siokas N/A Purchase 388.53K $0.37 $143.76K
Feb 11, 2026 Grigorios Siokas N/A Purchase 291.26K $0.41 $119.42K
Jan 23, 2026 Grigorios Siokas N/A Purchase 90.33K $0.50 $45.16K
Jan 20, 2026 Grigorios Siokas N/A Purchase 353.32K $0.50 $176.66K
Jan 14, 2026 Grigorios Siokas N/A Purchase 493.50K $0.45 $222.07K
Jan 12, 2026 Grigorios Siokas N/A Purchase 113.19K $0.50 $56.59K
Jan 08, 2026 Grigorios Siokas N/A Purchase 156.19K $0.52 $81.22K
Jan 07, 2026 Grigorios Siokas N/A Purchase 124.88K $0.52 $64.94K
Jan 06, 2026 Grigorios Siokas N/A Purchase 133.95K $0.54 $72.33K
Dec 19, 2025 Grigorios Siokas N/A Purchase 88.31K $0.49 $43.27K
Dec 15, 2025 Grigorios Siokas N/A Purchase 168.47K $0.42 $70.76K
Nov 28, 2025 Grigorios Siokas N/A Purchase 76.36K $0.64 $48.87K
Nov 25, 2025 Grigorios Siokas N/A Purchase 55.73K $0.63 $35.11K
Nov 21, 2025 Grigorios Siokas N/A Purchase 56.08K $0.68 $38.13K
Nov 20, 2025 Grigorios Siokas N/A Purchase 51.32K $0.62 $31.82K
Nov 19, 2025 Grigorios Siokas N/A Purchase 61.61K $0.65 $40.05K
May 23, 2025 Grigorios Siokas N/A Purchase 34.00K $0.45 $15.30K
May 22, 2025 Grigorios Siokas N/A Purchase 141.83K $0.44 $62.40K
May 21, 2025 Grigorios Siokas N/A Purchase 174.17K $0.47 $81.86K
May 20, 2025 Grigorios Siokas N/A Purchase 147.56K $0.45 $66.40K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Renaissance Technologies Corp 390.50K Mar 31, 2026 0.63% $0.00 16.72%
Geode Capital Management, LLC 318.11K Mar 31, 2026 0.51% $0.00 60.11%
BlackRock Inc 267.80K Mar 31, 2026 0.43% $0.00 0.00%
Vanguard Group Inc 235.74K Dec 31, 2025 0.38% $0.00 0.00%
Vanguard Capital Management, LLC 140.01K Mar 31, 2026 0.23% $0.00 0.00%
Vanguard Fiduciary Trust Co 95.74K Mar 31, 2026 0.15% $0.00 0.00%
HRT FINANCIAL LLC 67.28K Mar 31, 2026 0.11% $0.00 162.19%
State Street Corp 45.24K Mar 31, 2026 0.07% $0.00 0.00%
XTX Topco Ltd 40.48K Mar 31, 2026 0.07% $0.00 -59.36%
Citadel Advisors Llc 40.31K Mar 31, 2026 0.06% $0.00 -67.27%
Northern Trust Corp 20.55K Mar 31, 2026 0.03% $0.00 0.00%
Susquehanna International Group, LLP 17.73K Mar 31, 2026 0.03% $0.00 45.99%
UBS Group AG 12.73K Mar 31, 2026 0.02% $0.00 248.40%
NATIONAL BANK OF CANADA /FI/ 6.36K Mar 31, 2026 0.01% $0.00 0.00%
SIMPLEX TRADING, LLC 3.80K Mar 31, 2026 0.01% $0.00 -40.34%
Group One Trading, LLC 2.37K Mar 31, 2026 0.00% $0.00 -0.79%
Hanson Mcclain Inc 1.24K Mar 31, 2026 0.00% $0.00 0.00%
Citigroup Inc 990.00 Mar 31, 2026 0.00% $0.00 0.00%
Tower Research Capital LLC 755.00 Mar 31, 2026 0.00% $0.00 -3.58%
SBI Securities Co Ltd 112.00 Mar 31, 2026 0.00% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 228.34K 0.37% ▲ 0.00% May 31, 2026
2 Vanguard Institutional Extnd Mkt Idx Tr 173.97K 0.28% ▲ 0.00% Jun 30, 2026
3 NT Ext Equity Mkt Index Fund - NL 46.27K 0.07% ▲ 257.70% Jun 30, 2026
4 Extended Equity Market Fund E 40.81K 0.07% ▲ 0.00% Dec 31, 2025
5 Blackrock Extended Mkt Fund CF 40.81K 0.07% ▲ 0.00% May 31, 2026
6 Extended Equity Market Fund B 40.81K 0.07% ▲ 0.00% Dec 31, 2025
7 BlackRock Extended Equity Market Fund K 34.69K 0.06% ▼ 0.18% Jun 30, 2026
8 NT Ext Equity Mkt Idx Fd - DC - NL - T2 33.57K 0.05% ▲ 231.21% Jun 30, 2026
9 Fidelity Series Total Market Index 28.54K 0.05% ▲ 0.00% May 31, 2026
10 Fidelity Total Market Index 21.66K 0.03% ▲ 0.00% May 31, 2026

Financial Highlights

Market Cap: $12.88M
EBITDA: $-16.50M
PEG Ratio: $0.00
Book Value: $0.40
Earnings/Share: $-0.66
Profit Margin: -30.41%
Operating Margin: -12.18%
ROA (TTM): -18.71%
ROE (TTM): -92.32%
Revenue (TTM): $69.49M
Revenue/Share (TTM): $1.96
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 30.70%

Valuation Metrics

Enterprise Value: $29.28M
Trailing P/E: 0.00
Forward P/E: 20.00

Shares Statistics

Shares Outstanding: 62.08M
Shares Float: 33.93M
% Insiders: 3,398.50%
% Institutions: 509.50%
Short % Float: 11.88%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$65.27M
Cost of Goods Sold
adjust
$-57.38M
Gross Profit
subtotal
$7.90M
SG&A
adjust
$-22.40M
R&D
adjust
$-519.36K
Other Operating Expense
adjust
$-1.52M
Operating Income
subtotal
$-16.54M
Other / Non-Operating Items
adjust
$-2.60M
Net Income
subtotal
$-19.14M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about COSM.US!